Key steps for effective breast cancer prevention

KL Britt, J Cuzick, KA Phillips - Nature Reviews Cancer, 2020 - nature.com
Despite decades of laboratory, epidemiological and clinical research, breast cancer
incidence continues to rise. Breast cancer remains the leading cancer-related cause of …

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

N Pashayan, AC Antoniou, U Ivanus… - Nature reviews Clinical …, 2020 - nature.com
Abstract The European Collaborative on Personalized Early Detection and Prevention of
Breast Cancer (ENVISION) brings together several international research consortia working …

Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology

MB Daly, T Pal, MP Berry, SS Buys, P Dickson… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and
Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants …

Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline

NM Tung, JC Boughey, LJ Pierce… - Journal of clinical …, 2020 - ascopubs.org
PURPOSE To develop recommendations for management of patients with breast cancer
(BC) with germline mutations in BC susceptibility genes. METHODS The American Society …

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

K Metcalfe, A Eisen, L Senter, S Armel… - British journal of …, 2019 - nature.com
Background Women with a BRCA1 or BRCA2 mutation face high risks of breast and ovarian
cancer. In the current study, we report on uptake of cancer screening and risk-reduction …

BRCA Mutations and Breast Cancer Prevention

J Kotsopoulos - Cancers, 2018 - mdpi.com
Women who inherit a deleterious BRCA1 or BRCA2 mutation face substantially increased
risks of developing breast cancer, which is estimated at 70%. Although annual screening …

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

WP Weber, M Haug, C Kurzeder… - Breast cancer research …, 2018 - Springer
Purpose Indications for nipple-sparing mastectomy (NSM) have broadened to include the
risk reducing setting and locally advanced tumors, which resulted in a dramatic increase in …

Prepectoral versus subpectoral implant-based breast reconstruction: a systemic review and meta-analysis

E Ostapenko, L Nixdorf, Y Devyatko, R Exner… - Annals of surgical …, 2023 - Springer
Background Implant-based breast reconstruction (IBBR) remains the standard and most
popular option for women undergoing breast reconstruction after mastectomy worldwide …

A comparison of patient-reported outcomes after nipple-sparing mastectomy and conventional mastectomy with reconstruction

A Romanoff, EC Zabor, M Stempel, V Sacchini… - Annals of surgical …, 2018 - Springer
Introduction Nipple-sparing mastectomy (NSM) is increasingly used for breast cancer risk
reduction and treatment. Prior small studies with variable control for baseline characteristics …

Breast cancer in transgender patients: a systematic review. Part 2: female to male

JP Stone, RL Hartley, C Temple-Oberle - European Journal of Surgical …, 2018 - Elsevier
Transgender men or Female-to-Male (FtM) patients' risk of breast cancer and screening
recommendations remain unclear. The objective of this study is to perform a systematic …